Risks for Fast-tracked COVID-19 Vaccines

This podcast is part of ECRI's ongoing response to the COVID-19 pandemic. In today’s episode, Marcus Schabacker, MD, PhD, President and CEO of ECRI, discusses our position paper on the fast-tracked development of COVID-19 vaccines. During recent FDA public hearings and within the paper, ECRI warns that rushing to deploy vaccines before all the data has been collected and evaluated could lead to increased risk for patients, not to mention harm to public trust in vaccines in general. Interested in learning more? Contact us at (610) 825-6000 or clientservices@ecri.org.